TEVA FY 2008 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$34B

FY 2008 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11.1B+17.8% YoY

Gross Profit

$6.0B53.8% margin

Operating Income

$1.1B10.3% margin

Net Income

$635M5.7% margin

EPS (Diluted)

$0.78

Cash Flow

Operating Cash Flow

$3.2B

Free Cash Flow

$2.5B

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$32.9B

Total Liabilities

$16.5B

Stockholders' Equity

$16.3B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.1B	$9.4B	+17.8%
Gross Profit	$6.0B	$4.9B	+22.4%
Operating Income	$1.1B	$2.4B	-52.2%
Net Income	$635M	$2.0B	-67.5%